The invention provides anti-SARS-CoV-2 antibodies and use thereof in prophylaxis, treatment and/or attenuation of a SARS-CoV-2 virus infection.
Title
Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection
Date
2022
Note
Alternative title(s) : (fr) Anticorps anti-sars-cov-2 et leur utilisation dans le traitement d'une infection par le sars-cov-2
Other identifier(s)
EPO Family ID: 82308225
Record creation date
2023-02-06